
MD Biosciences is accredited by AAALAC International, demonstrating globally recognized excellence in animal care beyond regulatory standards.
MD Biosciences is a preclinical contract research organization with more than 30 years of experience in pain, CNS disorders and wound healing. Each study is designed to increase the clinical relevance of preclinical data. That work has helped move new drugs into the clinic and has been published in leading scientific journals.
MD Biosciences scientists design and run studies across the areas below, with models and readouts chosen for clinical relevance.

MD Biosciences is accredited by AAALAC International, demonstrating globally recognized excellence in animal care beyond regulatory standards.

The 20,000 square foot GLP facility supports translational research with dedicated rodent and pig labs, histology, biomarker, electrophysiology, and in vitro capabilities.

MD Biosciences holds an NIH Office of Laboratory Animal Welfare Foreign Assurance, confirming compliance with NIH animal care standards and enabling support of NIH-funded research conducted outside the United States.
MD Biosciences is a signatory to the Marseille Declaration, the first collective pharmaceutical industry commitment to advancing standards in animal housing and care. This reflects a commitment to the highest levels of animal welfare.
MD Biosciences is at the forefront of developing translational pig models, pioneering advanced methodologies and novel quantitative measures to de-risk clinical trials and drive success in neuroscience and pain research.